ImportRefusal LogoImportRefusal

NEOLPHARMA SA DE CV

⚠️ High Risk

FEI: 3014323004 • Mexico City • MEXICO

FEI

FEI Number

3014323004

📍

Location

Mexico City

🇲🇽

Country

MEXICO
🏢

Address

Blvd De Los Ferrocarril, , Mexico City, , Mexico

High Risk

FDA Import Risk Assessment

59.8
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

3
Total Refusals
1
Unique Violations
7/2/2025
Latest Refusal
2/13/2024
Earliest Refusal

Score Breakdown

Violation Severity
90.0×40%
Refusal Volume
22.3×30%
Recency
74.6×20%
Frequency
21.7×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

Refusal History

DateProductViolationsDivision
7/2/2025
62OAA09TELMISARTAN (ANTI-HYPERTENSIVE - PART II)
75UNAPPROVED
Division of Southeast Imports (DSEI)
7/2/2025
60LAA05ASPIRIN (ANALGESIC)
75UNAPPROVED
Division of Southeast Imports (DSEI)
2/13/2024
61MDY18PARAMETHADIONE (ANTI-CONVULSANT)
75UNAPPROVED
Division of Southeast Imports (DSEI)

Frequently Asked Questions

What is NEOLPHARMA SA DE CV's FDA import refusal history?

NEOLPHARMA SA DE CV (FEI: 3014323004) has 3 FDA import refusal record(s) in our database, spanning from 2/13/2024 to 7/2/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. NEOLPHARMA SA DE CV's FEI number is 3014323004.

What types of violations has NEOLPHARMA SA DE CV received?

NEOLPHARMA SA DE CV has been cited for 1 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about NEOLPHARMA SA DE CV come from?

All FDA import refusal data for NEOLPHARMA SA DE CV is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.